JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alauddin, M. M.
Right arrow Articles by Conti, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alauddin, M. M.
Right arrow Articles by Conti, P. S.
Journal of Nuclear Medicine Vol. 42 No. 11 1682-1690
© 2001 by Society of Nuclear Medicine


Basic Science Investigations

Preclinical Evaluation of the Penciclovir Analog 9-(4-[18F]Fluoro-3-Hydroxymethylbutyl)Guanine for In Vivo Measurement of Suicide Gene Expression with PET

Mian M. Alauddin, Antranik Shahinian, Erlinda M. Gordon, James R. Bading and Peter S. Conti

Department of Radiology, PET Imaging Science Center, University of Southern California, Los Angeles; and Gene Therapy Laboratory, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California

The gene for herpes simplex virus thymidine kinase (HSV-tk) is widely used as a suicide gene in experimental gene therapy of cancer. 9-(4-Fluoro-3-hydroxymethylbutyl)guanine (FHBG) is an antiviral nucleoside analog that is rapidly phosphorylated by viral thymidine kinase but is a poor substrate for mammalian thymidine kinase. Recently, FHBG labeled in the 4-fluoro position with 18F has shown promise relative to other similar compounds for imaging in vivo expression of HSV-tk using PET. In this study, we evaluated the uptake of [18F]FHBG in vitro and in vivo using transduced and wild-type human colon cancer cells (HT-29). We also imaged [18F]FHBG and measured the radioactivity concentrations of circulating [18F]FHBG and its metabolites in monkeys. Methods: Sterile, pyrogen-free [18F]FHBG was produced routinely in good yields. Cells were transduced with the retroviral vector G1Tk1SvNa containing HSV-tk gene. In vitro uptake studies were performed by incubating cells with [18F]FHBG at 37°C for 1 and 5 h. Biodistribution studies were performed at 2 and 5 h after injection in nude mice bearing tumors grown from wild-type or transduced cells. Sequential, whole-body PET scans of cynomolgus monkeys were obtained over a period of >2 h after intravenous injection of [18F]FHBG. Arterial plasma samples obtained from monkeys 15–120 min after intravenous injection were subjected to acid extraction, and the acid-soluble fractions were analyzed by high-performance liquid chromatography. Results: In vitro studies showed 31 and 71 (P < 0.001) times higher uptake of the probe at 1 and 5 h, respectively, in transduced cells compared with nontransduced cells. In vivo studies in mice showed that tumor uptake of the radiotracer was 4-fold (P < 0.05) and 13-fold (P < 0.001) higher at 2 and 5 h, respectively, in tumors grown from transduced cells compared with control cells. Transduced tumor-to-normal tissue ratios ranged from 2 to 25 at 2 h and from 2 to 22 at 5 h. Recirculating labeled metabolites had only a minor effect on the biodistribution of radiolabel from [18F]FHBG in monkeys. Conclusion: These results indicate that [18F]FHBG may yield high-contrast PET images of HSV-tk expression in tumors and, therefore, it is a very promising radiotracer for monitoring of gene therapy of cancer with PET.

Key Words: PET • gene therapy • [18F]FHBG • virus • colon cancer




This article has been cited by other articles:


Home page
JNMHome page
T. Miyagawa, G. Gogiberidze, I. Serganova, S. Cai, J. A. Balatoni, H. T. Thaler, L. Ageyeva, N. Pillarsetty, R. D. Finn, and R. G. Blasberg
Imaging of HSV-tk Reporter Gene Expression: Comparison Between [18F]FEAU, [18F]FFEAU, and Other Imaging Probes
J. Nucl. Med., April 1, 2008; 49(4): 637 - 648.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Jacobs, M. A. Rueger, A. Winkeler, H. Li, S. Vollmar, Y. Waerzeggers, B. Rueckriem, C. Kummer, C. Dittmar, M. Klein, et al.
Imaging-Guided Gene Therapy of Experimental Gliomas
Cancer Res., February 15, 2007; 67(4): 1706 - 1715.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Zhou, P. D. Acton, and V. A. Ferrari
Imaging Stem Cells Implanted in Infarcted Myocardium
J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2094 - 2106.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H.-E. Wang, H.-M. Yu, R.-S. Liu, M. Lin, J. G. Gelovani, J.-J. Hwang, H.-J. Wei, and W.-P. Deng
Molecular Imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for Monitoring Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Prodrug Activation Gene Therapy of Cancer
J. Nucl. Med., July 1, 2006; 47(7): 1161 - 1171.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. S. Yaghoubi, M. A. Couto, C.-C. Chen, L. Polavaram, G. Cui, L. Sen, and S. S. Gambhir
Preclinical Safety Evaluation of 18F-FHBG: A PET Reporter Probe for Imaging Herpes Simplex Virus Type 1 Thymidine Kinase (HSV1-tk) or Mutant HSV1-sr39tk's Expression
J. Nucl. Med., April 1, 2006; 47(4): 706 - 715.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. M. Alauddin, A. Shahinian, R. Park, M. Tohme, J. D. Fissekis, and P. S. Conti
Synthesis and Evaluation of 2'-Deoxy-2'-18F-Fluoro-5-Fluoro-1-{beta}-D-Arabinofuranosyluracil as a Potential PET Imaging Agent for Suicide Gene Expression
J. Nucl. Med., December 1, 2004; 45(12): 2063 - 2069.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Miyagawa, M. Anton, R. Haubner, M. V. Simoes, C. Stadele, W. Erhardt, S. Reder, T. Lehner, B. Wagner, S. Noll, et al.
PET of Cardiac Transgene Expression: Comparison of 2 Approaches Based on Herpesviral Thymidine Kinase Reporter Gene
J. Nucl. Med., November 1, 2004; 45(11): 1917 - 1923.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Serganova, M. Doubrovin, J. Vider, V. Ponomarev, S. Soghomonyan, T. Beresten, L. Ageyeva, A. Serganov, S. Cai, J. Balatoni, et al.
Molecular Imaging of Temporal Dynamics and Spatial Heterogeneity of Hypoxia-Inducible Factor-1 Signal Transduction Activity in Tumors in Living Mice
Cancer Res., September 1, 2004; 64(17): 6101 - 6108.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. D. Luker, V. Sharma, C. M. Pica, J. L. Prior, W. Li, and D. Piwnica-Worms
Molecular Imaging of Protein-Protein Interactions: Controlled Expression of p53 and Large T-Antigen Fusion Proteins in Vivo
Cancer Res., April 15, 2003; 63(8): 1780 - 1788.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. G. Tjuvajev, M. Doubrovin, T. Akhurst, S. Cai, J. Balatoni, M. M. Alauddin, R. Finn, W. Bornmann, H. Thaler, P. S. Conti, et al.
Comparison of Radiolabeled Nucleoside Probes (FIAU, FHBG, and FHPG) for PET Imaging of HSV1-tk Gene Expression
J. Nucl. Med., August 1, 2002; 43(8): 1072 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. D. Luker, V. Sharma, C. M. Pica, J. L. Dahlheimer, W. Li, J. Ochesky, C. E. Ryan, H. Piwnica-Worms, and D. Piwnica-Worms
Noninvasive imaging of protein-protein interactions in living animals
PNAS, May 14, 2002; 99(10): 6961 - 6966.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.